PagetDiseaseTamoxifenMRIFlowCytometryAdenocarcinomaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearOvarianSuppressionBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MetastasisER+BOCABiopsyAxillarySamplingBreastTomosynthesisLapatinibKi-67RateRelapseAntibodyTherapyGermlineMutation5-FluorouracilAdjuvantTherapyMegestrolAcetateAyurvedaDoxorubicinIntraductalPapillomaDown-StagingBRCAGeneRaloxifeneProgestinFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HerceptinCheckpointInhibitorGeneMutationOligometastasesSelf-examinationFamilyHistoryBilateralProphylacticMastectomyCapecitabineRadiotherapyPI3KinaseInhibitorsDimplingLumpMultifocalTumorsSERMMastodyniaPARPInhibitorsDocetaxelIn-situCarcinomaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.African-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenDoseDenseTherapyLCISImmunotherapyCytostaticCDK4/6InhibitorsMorpheaAlopeciaFISHEstradiolFibroadenomaTriple +/-BreastCancerAromataseInhibitorsBreastCancerMethotrexatePhysicalactivity mayreduce therisk of breastcancersPrecisionMedicinePaclitaxelEGFRGuaranteedRenewableInsurancePalpationChemopreventionMastectomyCachexiaECOGScoreCytotoxicEstrogenWomen ages40+ shouldhave a clinicalbreast examat least yearlyBI-RADSHormoneReplacementTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerApoptosisAdvocacyTumorGradeACChemotherapyER-BrachytherapyAbsoluteRiskCystLymphoscintigraphyPathologicResponseAnastrozoleStagingmTORInhibitorsAntiemeticNeoadjuvantTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCyclophosphamide1 in 8womenChemotherapyLymphNodeStatusGeneticCounselingCMFChemotherapyRADDefinitiveSurgeryHormoneReceptorStatusGenomicTestingGeneticPredispositionTyrosine-KinaseInhibitorPalbociclibCalcificationsLumpectomyCAMMultimodalityTherapyHER-2Co-survivorPhyllodesTumorGailModelAngiogenesisBevacizumabKappaEpsilonPagetDiseaseTamoxifenMRIFlowCytometryAdenocarcinomaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearOvarianSuppressionBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MetastasisER+BOCABiopsyAxillarySamplingBreastTomosynthesisLapatinibKi-67RateRelapseAntibodyTherapyGermlineMutation5-FluorouracilAdjuvantTherapyMegestrolAcetateAyurvedaDoxorubicinIntraductalPapillomaDown-StagingBRCAGeneRaloxifeneProgestinFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HerceptinCheckpointInhibitorGeneMutationOligometastasesSelf-examinationFamilyHistoryBilateralProphylacticMastectomyCapecitabineRadiotherapyPI3KinaseInhibitorsDimplingLumpMultifocalTumorsSERMMastodyniaPARPInhibitorsDocetaxelIn-situCarcinomaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.African-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenDoseDenseTherapyLCISImmunotherapyCytostaticCDK4/6InhibitorsMorpheaAlopeciaFISHEstradiolFibroadenomaTriple +/-BreastCancerAromataseInhibitorsBreastCancerMethotrexatePhysicalactivity mayreduce therisk of breastcancersPrecisionMedicinePaclitaxelEGFRGuaranteedRenewableInsurancePalpationChemopreventionMastectomyCachexiaECOGScoreCytotoxicEstrogenWomen ages40+ shouldhave a clinicalbreast examat least yearlyBI-RADSHormoneReplacementTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerApoptosisAdvocacyTumorGradeACChemotherapyER-BrachytherapyAbsoluteRiskCystLymphoscintigraphyPathologicResponseAnastrozoleStagingmTORInhibitorsAntiemeticNeoadjuvantTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCyclophosphamide1 in 8womenChemotherapyLymphNodeStatusGeneticCounselingCMFChemotherapyRADDefinitiveSurgeryHormoneReceptorStatusGenomicTestingGeneticPredispositionTyrosine-KinaseInhibitorPalbociclibCalcificationsLumpectomyCAMMultimodalityTherapyHER-2Co-survivorPhyllodesTumorGailModelAngiogenesisBevacizumabKappaEpsilon

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Paget Disease
  2. Tamoxifen
  3. MRI
  4. Flow Cytometry
  5. Adenocarcinoma
  6. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  7. Ovarian Suppression
  8. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  9. Metastasis
  10. ER+
  11. BOCA
  12. Biopsy
  13. Axillary Sampling
  14. Breast Tomosynthesis
  15. Lapatinib
  16. Ki-67 Rate
  17. Relapse
  18. Antibody Therapy
  19. Germline Mutation
  20. 5-Fluorouracil
  21. Adjuvant Therapy
  22. Megestrol Acetate
  23. Ayurveda
  24. Doxorubicin
  25. Intraductal Papilloma
  26. Down-Staging
  27. BRCA Gene
  28. Raloxifene
  29. Progestin
  30. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  31. Herceptin
  32. Checkpoint Inhibitor
  33. Gene Mutation
  34. Oligometastases
  35. Self-examination
  36. Family History
  37. Bilateral Prophylactic Mastectomy
  38. Capecitabine
  39. Radiotherapy
  40. PI3 Kinase Inhibitors
  41. Dimpling
  42. Lump
  43. Multifocal Tumors
  44. SERM
  45. Mastodynia
  46. PARP Inhibitors
  47. Docetaxel
  48. In-situ Carcinoma
  49. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  50. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  51. Dose Dense Therapy
  52. LCIS
  53. Immunotherapy
  54. Cytostatic
  55. CDK4/6 Inhibitors
  56. Morphea
  57. Alopecia
  58. FISH
  59. Estradiol
  60. Fibroadenoma
  61. Triple +/- Breast Cancer
  62. Aromatase Inhibitors
  63. Breast Cancer
  64. Methotrexate
  65. Physical activity may reduce the risk of breast cancers
  66. Precision Medicine
  67. Paclitaxel
  68. EGFR
  69. Guaranteed Renewable Insurance
  70. Palpation
  71. Chemoprevention
  72. Mastectomy
  73. Cachexia
  74. ECOG Score
  75. Cytotoxic
  76. Estrogen
  77. Women ages 40+ should have a clinical breast exam at least yearly
  78. BI-RADS
  79. Hormone Replacement Therapy
  80. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  81. Apoptosis
  82. Advocacy
  83. Tumor Grade
  84. AC Chemotherapy
  85. ER-
  86. Brachytherapy
  87. Absolute Risk
  88. Cyst
  89. Lymphoscintigraphy
  90. Pathologic Response
  91. Anastrozole
  92. Staging
  93. mTOR Inhibitors
  94. Antiemetic
  95. Neoadjuvant Therapy
  96. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  97. Cyclophosphamide
  98. 1 in 8 women
  99. Chemotherapy
  100. Lymph Node Status
  101. Genetic Counseling
  102. CMF Chemotherapy
  103. RAD
  104. Definitive Surgery
  105. Hormone Receptor Status
  106. Genomic Testing
  107. Genetic Predisposition
  108. Tyrosine-Kinase Inhibitor
  109. Palbociclib
  110. Calcifications
  111. Lumpectomy
  112. CAM
  113. Multimodality Therapy
  114. HER-2
  115. Co-survivor
  116. Phyllodes Tumor
  117. Gail Model
  118. Angiogenesis
  119. Bevacizumab
  120. Kappa Epsilon